Having discovered the palmitoylation motif of APLNR, we created a short substrate sequence to competitively inhibit the palmitoylation of endogenous APLNR. This competitive peptide, which targets the APLNR palmitoylation web-site together with morphine, can inhibit the development of NCP, which include pain incidence, microglial activation, and inflammatory component release https://reubenm703dau1.laowaiblog.com/profile